US Broker Ratings

Akso Health Group (AHG) Stock Analysis: Navigating the Intricacies of a Unique Medical Distributor in China’s Healthcare Sector

Akso Health Group (AHG), with a market capitalization of $1.82 billion, operates at the intersection of healthcare and e-commerce in China. Positioned within the medical distribution..

Community Health Systems, Inc. (CYH) Stock Analysis: Navigating the Healthcare Sector with a 12.73% Upside Potential

Community Health Systems, Inc. (NYSE: CYH), a prominent player in the healthcare sector, is capturing attention with its potential upside of 12.73%. Headquartered in Franklin, Tennessee,..

Auna SA (AUNA)

⚠️ No article content returned.

..

OrthoPediatrics Corp. (KIDS) Stock Analysis: A Compelling 50% Upside Potential Drives Investor Interest

OrthoPediatrics Corp. (NASDAQ: KIDS), a prominent player in the healthcare sector and medical devices industry, has captured investor attention with its substantial growth potential. Trading at..

Maravai LifeSciences Holdings (MRVI) Stock Analysis: A Closer Look at a 34.90% Potential Upside

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a notable player in the biotechnology sector, is drawing attention from investors with a striking potential upside of 34.90%. Despite..

Nuvation Bio Inc. (NUVB): Consensus Shows a Potential 156% Upside for this Biotech Innovator

As the global healthcare sector continues to capture the attention of investors, Nuvation Bio Inc. (NASDAQ: NUVB) emerges as a compelling opportunity in the biotechnology industry...

LENZ Therapeutics, Inc. (LENZ)

⚠️ No article content returned.

..

GH Research PLC (GHRS) Rating Update: A Biotech Stock with 121% Potential Upside

GH Research PLC (NASDAQ: GHRS), a promising player in the biotechnology sector, has caught the attention of investors with its remarkable potential upside of 121.25%. Based..

CareDx, Inc. (CDNA) Stock Analysis: Exploring Growth Potential and Analyst Consensus

CareDx, Inc. (NASDAQ: CDNA), a key player in the healthcare sector with a focus on diagnostics and research, has been gaining traction among investors due to..

Kura Oncology, Inc. (KURA) Stock Analysis: A 247% Upside Potential Beckons Investors

Kura Oncology, Inc. (NASDAQ: KURA) has captured the attention of investors in the healthcare sector, with a market cap of $793.54 million. As a clinical-stage biopharmaceutical..

Tyra Biosciences, Inc. (TYRA) Stock Analysis: Unveiling a 45.89% Potential Upside in Biotech Innovation

Tyra Biosciences, Inc. (NASDAQ: TYRA), a promising name in the biotechnology sector, has caught the attention of investors with its cutting-edge approach to precision medicine. Based..

CeriBell, Inc. (CBLL) Stock Analysis: Analysts See 32.94% Upside Potential in Innovative Medical Technology

CeriBell, Inc. (CBLL), a dynamic player in the healthcare sector specializing in medical devices, is capturing investor attention with its cutting-edge approach to acute care diagnostics...

Keros Therapeutics, Inc. (KROS) Stock Analysis: Exploring a Potential 92.59% Upside in the Biotech Industry

Keros Therapeutics, Inc. (NASDAQ: KROS), a clinical-stage biopharmaceutical company based in Lexington, Massachusetts, is capturing the attention of investors with its promising pipeline and significant potential..

Bicara Therapeutics Inc. (BCAX) Stock Analysis: Assessing a 27% Upside Potential for this Biotech Innovator

Bicara Therapeutics Inc. (NASDAQ: BCAX) offers a compelling narrative in the biotechnology sector, commanding attention with its innovative approach to solid tumor treatment and a promising..

Fulgent Genetics, Inc. (FLGT) Investor Outlook: Uncovering a 50.86% Potential Upside in the Diagnostics Sector

Fulgent Genetics, Inc. (NASDAQ: FLGT) stands at a fascinating juncture within the healthcare sector, particularly in the diagnostics and research industry. With a market capitalization of..

KalVista Pharmaceuticals (KALV): A Biotech Gem with 75% Upside Potential

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) is emerging as an intriguing opportunity in the biotech sector, capturing investor attention with its promising pipeline and significant upside potential...

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: A Promising Biotech with 12.48% Potential Upside

Enliven Therapeutics, Inc. (NASDAQ: ELVN), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its promising pipeline of cancer treatment drugs...

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring the 547% Potential Upside

Anavex Life Sciences Corp. (NASDAQ: AVXL) presents an intriguing opportunity for investors in the biotech sector, particularly given its remarkable potential upside of 547.06%. This New..

Praxis Precision Medicines, Inc. (PRAX) Stock Analysis: A Biotech with Nearly 100% Upside Potential

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company, has captured the attention of investors with its focus on innovative therapies for central nervous system..

Iovance Biotherapeutics (IOVA) Stock Analysis: A 137% Potential Upside Sparks Investor Interest

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is capturing the attention of savvy investors, thanks to a promising potential upside of 136.84% based on the average analyst target..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds